ArticleMolecular oncology2017

T-cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancer.

Jian-Feng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.